The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2009Exploring Serotonergic Cortical Targets for Treatment of Parkinson's Disease Using a Mathematical Disease Model
Objective/Rationale:
Because animal models have limited predictability for clinical outcomes of experimental Parkinson drugs, a complex mathematical model of the interactions between key motor... -
Rapid Response Innovation Awards, 2009The Effect of 4-hydroxy-2-nonenal Modification on Alpha-synuclein Toxicity
Objective/Rationale:
Alpha-synuclein is a protein that is normally produced in the human brain. Compelling evidence suggests that alpha-synuclein can acquire a toxic feature that kills dopamine... -
Rapid Response Innovation Awards, 2009Enzymes that Catalyze for Alpha-synuclein Ubiquitination and Degradation
Objective/Rationale:
A characteristic feature of Parkinson’s disease (PD) is the buildup of the protein, alpha-synuclein, and overproduction of this protein can trigger PD. Therefore, it is important... -
Rapid Response Innovation Awards, 2009Small Molecule Inhibitors of Alpha-synuclein Assembly and Toxicity
Objective/Rationale:
We will test a novel drug candidate that blocks formation of the toxic aggregates of the protein alpha-synuclein, which are believed to cause Parkinson’s disease (PD). Our drug... -
Target Validation, 2009Upregulation of MsrA: A Neuroprotective Strategy for the Treatment of Parkinson's Disease
Objective/Rationale:
The death of neurons in the brains of Parkinson’s disease (PD) patients involves a buildup of agents that cause oxidative stress, resulting in damage to proteins, lipids, and DNA... -
Therapeutics Development Initiative, 2009Exploring Curcumin and Curcumin Derivatives as Putative Epigenetic Target of Histone Deacetylase (HDAC) Inhibition in Parkinson's Disease
Objective/Rationale:
Our project is to explore cutting-edge nano- biotechnology advances in formulating curcumin extracted from Curry as potential drug candidates in treatment of Parkinson disease...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.